Search Results
Sort by:
Filter 0
Sort by
04 October 2022 - EA03
Cefepime-taniborbactam and comparator activity in vitro against carbapenem-resistant Enterobacterales (CRE), carbapenem-resistant P. aeruginosa (CRPA) and multidrug-resistant (MDR) Enterobacterales and P. aeruginosa from 2018-2020 global surveillance
12 July 2021 - 2337
In vitro activity of imipenem/relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa isolates from patients with respiratory tract infections in the Asia/Pacific region: SMART 2017-2019
11 July 2021 - 1593
In vitro activity of aztreonam/avibactam and comparator agents against multidrug-resistant Enterobacterales collected globally as part of the ATLAS Surveillance Program, 2016-2019
09 July 2021 - 2564
Antimicrobial activity of cefepime in combination with taniborbactam (formerly VNRX-5133) against a european 2018-2020 surveillance collection of Pseudomonas aeruginosa
09 July 2021 - 2581
Antimicrobial activity of cefepime in combination with taniborbactam (formerly VNRX-5133) against clinical isolates of Enterobacterales from Europe collected from 2018-2020 surveillance
09 July 2021 - 1588
In vitro activities of aztreonam/avibactam and comparator agents against metallo-β-lactamase-producing Enterobacterales collected during the ATLAS Global Surveillance Program, 2016-2019
09 July 2021 - 1041
In Vitro activity of aztreonam/avibactam and comparator agents against Enterobacterales from Europe collected during the ATLAS Global Surveillance Program, 2015-2019
09 July 2021 - 1037
In vitro Activities of Ceftazidime-avibactam and Comparator Agents against Gram-negative isolates from China as Part of the ATLAS Global Surveillance Program 2019
09 July 2021 - 1044
In Vitro activities of aztreonam/avibactam and comparator agents against carbapenemase-producing Enterobacterales collected during the ATLAS Global Surveillance Program, 2015-2019
09 July 2021 - 750
In vitro activity of ceftazidime-avibactam and comparators against isolates of Enterobacterales and Pseudomonas aeruginosa collected from paediatric patients as part of the ATLAS global surveillance programme, 2013-2019
09 July 2021 - 752
In vitro activities of ceftazidime-avibactam and comparators against Pseudomonas aeruginosa from Europe stratified by infection type, ATLAS global surveillance programme, 2016-2019
09 July 2021 - 751
In vitro activities of ceftazidime-avibactam and comparator agents against Enterobacterales isolates collected in Europe stratified by infection type , from the ATLAS global surveillance programme, 2016-2019
09 July 2021 - 2186
In vitro activities of ceftaroline and comparator agents against bacterial pathogens collected from patients with skin and soft tissue infections in Europe: a regional analysis of results from the ATLAS surveillance program 2015-2019
09 July 2021 - 2163
European regional analysis of the in vitro activities of ceftaroline and comparator agents against bacterial pathogens frequently isolated from patients with community-acquired respiratory tract infections: ATLAS surveillance programme 2015-2019
09 July 2021 - 2139
In vitro activities of ceftaroline and comparator agents against bacterial pathogens frequently causing community-acquired respiratory tract infections in patients from Latin America: ATLAS surveillance programme 2016-2019
09 July 2021 - 377
Five-year susceptibility trends of cefiderocol against Gram-negative bacteria collected in North America and five European countries between 2014 and 2019: SIDERO-WT-2014-2019 studies
09 July 2021 - 2493
Antimicrobial susceptibility to ceftolozane/tazobactam and comparators among Gram-negative isolates collected from patients in South Africa: SMART 2017-2019
09 July 2021 - 2453
Antimicrobial susceptibility to ceftolozane/tazobactam and comparators among Gram-negative isolates collected from patients in Morocco: SMART 2016-2019
09 July 2021 - 2408
Antimicrobial susceptibility to ceftolozane/tazobactam and comparators amongst Pseudomonas aeruginosa isolates collected from patients in hospitals in the Middle East & Africa: SMART 2017-2019
09 July 2021 - 2529
Antimicrobial susceptibility to ceftolozane/tazobactam, imipenem/relebactam and comparators among Gram-negative isolates collected from patients in the Balkan region: SMART 2016-2019
Loading ...
+ load more
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.